Cargando…
Dienogest May Reduce Estradiol- and Inflammatory Cytokine-Induced Cell Viability and Proliferation and Inhibit the Pathogenesis of Endometriosis: A Cell Culture- and Mouse Model-Based Study
Dienogest (DNG) is a therapeutic medication used in endometriosis treatment. Limited data are available regarding its mechanism of action on endometrial cells. Using in vivo and in vitro models, we investigated whether DNG treatment causes significant biological changes in human endometrial stromal...
Autores principales: | Kim, Hyun Jin, Kim, Sung Hoon, Oh, Young Sang, Lee, Sa Ra, Chae, Hee Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687141/ https://www.ncbi.nlm.nih.gov/pubmed/36428561 http://dx.doi.org/10.3390/biomedicines10112992 |
Ejemplares similares
-
Dienogest and the Risk of Reoperation in Endometriosis
por: Seo, Yong-Soo, et al.
Publicado: (2021) -
Contraception with estradiol valerate and dienogest: adherence to the method
por: Fruzzetti, Franca, et al.
Publicado: (2019) -
Dienogest in long-term treatment of endometriosis
por: Schindler, Adolf E
Publicado: (2011) -
Study of dienogest for dysmenorrhea and pelvic pain associated with endometriosis
por: Kim, Soo Ah, et al.
Publicado: (2016) -
Efficacy and safety of dienogest in patients with endometriosis: A single-center observational study over 12 months
por: Park, So Yun, et al.
Publicado: (2016)